Physician profile
Andrej Strapko
NPI 1700845997
$4,307.75
in general payments reported to CMS, 2019-2025
35 companies · $911 in 2025
The $911 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $336 · 2021: $611 · 2022: $416 · 2023: $686 · 2024: $880 · 2025: $911.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,476.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $981.34 | 2019-2025 | Rinvoq, Skyrizi, Mavyret |
| Janssen Biotech, INC. | $600.55 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $386.84 | 2019-2025 | Entyvio, Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $240.74 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Phathom Pharmaceuticals, INC. | $213.97 | 2023-2025 | Voquezna |
| Pfizer INC. | $196.78 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $189.18 | 2022-2025 | Dupixent |
| Ferring Pharmaceuticals INC. | $182.78 | 2019-2024 | Rebyota |
| Braintree Laboratories, INC. | $124.60 | 2019-2022 | |
| Gilead Sciences, INC. | $123.66 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $91.04 | 2019-2024 | Dificid |
| Ipsen Biopharmaceuticals, INC | $79.74 | 2025 | Iqirvo |
| Qol Medical, LLC | $77.71 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $75.78 | 2020-2022 | |
| Intercept Pharmaceuticals, INC. | $72.66 | 2019-2023 | Ocaliva |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $62.41 | 2022-2023 | Ibsrela |
| Cook Medical LLC | $60.68 | 2020-2022 | |
| Genzyme Corporation | $58.19 | 2025 | |
| Exact Sciences Corporation | $57.62 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $52.03 | 2025 | Wegovy |
| Lilly USA, LLC | $47.92 | 2024-2025 | Omvoh |
| Redhill Biopharma INC. | $43.83 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $41.22 | 2023 | Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.85 | 2023 | Cyltezo |
| Celltrion USA INC. | $27.18 | 2024 | Zymfentra |
| Shire North American Group INC | $25.81 | 2019 | |
| Madrigal Pharmaceuticals | $25.06 | 2025 | Rezdiffra |
| Organon LLC | $24.54 | 2024 | |
| Eagle Pharmaceuticals, INC. | $22.83 | 2023 | |
| Boston Scientific Corporation | $16.67 | 2021 | |
| Celgene Corporation | $14.55 | 2021 | |
| Fujifilm Healthcare Americas Corporation | $14.35 | 2022 | |
| Sandoz INC. | $12.80 | 2023 | Hyrimoz |
| Allergan, INC. | $12.15 | 2019 | |
| Meridian Bioscience INC. | $9.69 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrej Strapko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.